Intraosseous route of administration for delivering drugs has been traditionally used to gain vascular access in patients suffering from crtitical illness. Vascular access in patients suffering from life-threatening conditions or in case of medical emergencies has been essentially performed through intravenous access/route (IV), which has been the cornerstone in the drug delivery, particularly when high volume of medication is to be administered. However, certain medical conditions make it difficult to establish an efficient intravenous route, especially in conditions such as low blood pressure or in pediatric cases. This could result in serious conditions in patients suffering from chronic diseases. Hence, a safer and faster route of administration such as intraosseous route (IO) is required. This is performed by accessing the bone marrow directly with the help of various access devices, which enable health care providers to establish a quicker and more reliable vascular access in patients for delivery of drugs.
Get Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37775
The global intraosseous devices market is driven by increase in incidence of trauma and accident cases across the world, presenting large population requiring quick and reliable vascular access for treatment of patients, rise in incidence of chronic diseases including cancer, and new and advanced products and devices with improved efficiency being introduced in the global market. New automatic intraosseous devices such as PerSys Medical’s Bone Injection Gun (BIG) and Teleflex Incorporated’s EZ-IO are the recently introduced devices in the intraosseous devices market. These are gaining increasing adoption and acceptance by health care providers which is expected to drive the global market from 2017 to 2025. However, lack of awareness among general population and health care providers in emerging countries about the new and advanced intraosseous devices along with persistent preference for IV route are expected to restrain the global intraosseous devices market during the forecast period.
The global intraosseous devices market can be segmented based on device type, end-user, and region. In terms of device type, the global market can be categorized into manual intraosseous devices, semi-automatic intraosseous devices, and automatic intraosseous devices. The semi-automatic intraosseous devices segment is expected to dominate the global market in 2017 because of higher preference of health care providers for these devices due to lower health care associated costs and new and advanced product introductions by market players in this segment. However, the automatic intraosseous devices segment in expected to register comparatively higher CAGR during the forecast period, due to distinct advantages over semi-automatic devices. Based on end-user, the global intraosseous devices market can be classified into hospitals, ambulatory care centers, specialty clinics, urgent care centers, and others. The urgent care centers segment is expected to expand at a high CAGR owing to increase in traumatic surgeries being performed in these settings in emerging countries such as Brazil, China, and India. The hospitals segment is expected to dominate the global intraosseous devices market from 2017 to 2025. This is attributed to large patient population suffering from chronic diseases being treated in hospital settings in Asia Pacific, Latin America, and Middle East & Africa.